CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer

Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang

Cancer Research and Treatment. 2018;50(4):1324-1330. Published online 2018 January 8 DOI: https://doi.org/10.4143/crt.2017.526

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

Niki Karachaliou, Aris Polyzos, Nikolaos Kentepozidis, Stylianos Kakolyris, Nikolaos Ziras, Nikolaos Vardakis, Antonia Kalykaki, Georgia Milaki, Vassilis Georgoulias, Nikolaos Androulakis

Oncology. 2010;78(5-6):356-360

Link1 Link2

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer

Cancer Research and Treatment. 2018;50(4):1324-1330

Link1

Link2 Link3

703 PUBLICATION Phase II multicenter study of capecitabine plus oxaliplatin (XELOX) sequentially followed by capecitabine and irinotecan (XELIRI) in first-line therapy for metastatic colorectal cancer (MCRC)

European Journal of Cancer Supplements. 2005;3(2):199-200

Link1 Link2

A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer

Naminatsu Takahara, Yousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, Yuji Morine, Kazuo Watanabe, Makoto Ueno, Tatsuya Ioka, Masashi Kanai, Shunsuke Kondo, Naohiro Okano, Kazuhiko Koike

. 2022;

Link1 Link2

627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

European Journal of Cancer Supplements. 2005;3(2):177

Link1 Link2

Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)

C. Yoo, B. Han, K-P. Kim, H.S. Kim, J.H. Kim, H-M. Chang, B-Y. Ryoo, D.Y. Zang

Annals of Oncology. 2017;28:v244-v245

Link1 Link2 Link3

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

Junji Furuse, Takuji Okusaka, Narikazu Boku, Shinichi Ohkawa, Akira Sawaki, Toshikazu Masumoto, Akihiro Funakoshi

Cancer Chemotherapy and Pharmacology. 2008;62(5):849-855

Link1

Link2 Link3

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

S Y Kim, Y S Hong, E K Shim, S-Y Kong, A Shin, J Y Baek, K H Jung

British Journal of Cancer. 2013;109(6):1420-1427

Link1

Link2 Link3

707 PUBLICATION Capecitabine, oxaliplatin and irinotecan combination: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study

European Journal of Cancer Supplements. 2005;3(2):200-201

Link1 Link2

A Prospective Multicenter Phase II Study of Cisplatin and Weekly Docetaxel as First-Line Treatment of Recurrent or Metastatic NAsopharyngeal Cancer (KCSG HN07-01)

J.H. Ji

Annals of Oncology. 2012;23:xi156

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.